Hologic, Inc. provided preliminary revenue guidance for first fiscal quarter ended December 25, 2021. For the quarter, the company expects to report total revenues of approximately $1,471.1 million, a decrease of (8.6%) compared to the prior year period, or (8.2%) in constant currency. These preliminary results compare to the Company's most recent guidance range of $1,100 to $1,150 million, which was provided on November 1, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72.27 USD | +0.87% | +1.12% | +1.15% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.15% | 16.87B | |
+5.16% | 213B | |
+9.62% | 188B | |
+31.18% | 157B | |
+33.37% | 113B | |
+3.46% | 64.85B | |
+1.51% | 49.1B | |
-4.27% | 38.83B | |
+0.88% | 35.6B | |
+8.44% | 27.4B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Hologic, Inc. Provides Preliminary Revenue Guidance for First Fiscal Quarter Ended December 25, 2021